DXR - רווח תפעולי לפני ניכוי פחת Daxor

The risk of stagnating equipment demand is offset by stable cash flow, as confirmed by the EBITDA trend on the GURU.Markets chart, where the 6.29 level indicates the parameter's status. Daxor Corporation (DXR) ensures business resilience through partnerships with cardiology centers treating heart failure and the implementation of the BVA-100 system, which creates high hospital dependency on proprietary software.
Daxor (DXR) - פילוחי מדדים ודוחות פיננסיים

To protect capital amid volatility, it is critical for investors to track real cash flow from sales without the influence of debt burdens and taxes. An analysis of EBITDA allows for the identification of hidden efficiency trends for the BVA-100, confirming that unique blood volume diagnostics translate into sustainable operational growth and capitalization for Daxor Corporation (DXR).